verified SJR 0,736 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom

workspace_premium Q2 — Oncology lock_open Open Access

Best Practice and Research in Clinical Haematology

Best Practice and Research in Clinical Haematology is a journal indexed in SJR in Oncology and Clinical Biochemistry with an H index of 82. It has an SJR impact factor of 0,736 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,736.

Best Practice and Research in Clinical Haematology focuses its scope in these topics and keywords: myeloid, peripheral, cell, solid, tcell, therapy, tnkcell, genetics, leukemia, treatment, ...

ISSN: 1521-6926

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,736 Q2

H-index 82

Acceptance rate pie_chart

27% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,736

H-index

Docs (year)

Docs 3y

149

Total refs

2265

Cites 3y

299

Citable 3y

140

Cites/Doc 2y

1.99

Ref/Doc

64.71

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Positive selection of autologous peripheral blood stem cells

Preface

Safety and efficacy in retrovirally modified haematopoietic cell therapy

Stem cell transplantation for Crohn's disease

T-cell depletion of allogeneic peripheral blood stem cells

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

Treatment of acute myeloid leukaemia in younger patients

Venous thromboembolism in neonates and children

Relapsed acute myeloid leukemia: Why is there no standard of care?

Preface

SHOW MORE ARTICLES

Preface

Peripheral blood stem cell transplantation in breast cancer

Peripheral blood stem cell and gene therapy

Overview

Oral iron chelators -development and application

Normal and leukaemic haematopoiesis in bone marrow and peripheral blood of patients with chronic myeloid leukaemia

Negative selection of autologous peripheral blood stem cells

Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF

Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia

It is time to change thrombosis risk assessment for PV and ET?

Is the focus moving toward a combination of targeted drugs?

Iron and infection: competition between host and microbes for a precious element

FAQs

Best Practice and Research in Clinical Haematology has an SJR of 0,736 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Best Practice and Research in Clinical Haematology is 27%.

Best Practice and Research in Clinical Haematology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Best Practice and Research in Clinical Haematology?

What is the APC / publication cost?

What is the acceptance rate?